The poster presented data from AUTX-703, a potent, selective and orally bioavailable heterobifunctional degrader of KAT2A/B, an AURIGIN-identified histone acetyltransferase driving small cell lung ...

Lung cancer screening has the potential to catch lung cancer early and save lives-but only if people get screened. Although lung cancer screening is recommended in the U.S. for certain individuals ...

New research delves into the DNA details and chromatin structures that may predict prognosis in early-stage lung ...

A significant study detailing OncoSeek®'s efficacy was published in eClinicalMedicine, a clinical journal of The Lancet, titled A panel o ...

Merck has filed a petition with the U.S. Patent and Trademark Office to challenge seven of Halozyme’s patents. Halozyme said ...

Every year, 1.8 million people lose their lives to lung cancer, making it one of the deadliest diseases and one of the leading causes of cancer-related deaths worldwide. A major reason for the high ...

Stage 4 non-small cell lung cancer (NSCLC ... Chemotherapy generally starts killing cancer cells and reducing tumor size within a few weeks, whereas immunotherapy takes longer, at least a couple ...

Airway inflammation is increasingly recognized as a key factor in the pathogenesis and progression of non-small cell lung cancer (NSCLC ... including tumor characteristics, systemic inflammatory ...

Whalen, PhD, poses a new explanation for how cancer-fighting drugs attack and destroy BRCA1 and BRCA2 tumor cells. Published in Nature Cancer, their work illustrates how a small DNA nick-a break ...